184
Views
45
CrossRef citations to date
0
Altmetric
Original Research

Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease – associations with disease phenotype, treatment, and outcome

, , , , , , , , , , , , , , , , , , & show all
Pages 37-49 | Published online: 31 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Zengrong Wu, Deliang Liu & Feihong Deng. (2022) The Role of Vitamin D in Immune System and Inflammatory Bowel Disease. Journal of Inflammation Research 15, pages 3167-3185.
Read now
S. Vatn, A. Carstens, A. B. Kristoffersen, D. Bergemalm, C. Casén, A. E. F. Moen, T. M. Tannaes, J. Lindstrøm, T. E. Detlie, C. Olbjørn, C. M. Lindquist, J. D. Söderholm, F. Gomollón, R. Kalla, J. Satsangi, M. H. Vatn, J. Jahnsen, J. Halfvarson & P. Ricanek. (2020) Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character). Scandinavian Journal of Gastroenterology 55:10, pages 1146-1156.
Read now
Mikkel Malham, Berit Lilje, Gunnar Houen, Katrine Winther, Paal S. Andersen & Christian Jakobsen. (2019) The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease. Scandinavian Journal of Gastroenterology 54:8, pages 969-975.
Read now

Articles from other publishers (42)

Ioanna Aggeletopoulou, Markos Marangos, Stelios F. Assimakopoulos, Athanasia Mouzaki, Konstantinos Thomopoulos & Christos Triantos. (2023) Vitamin D and Microbiome. The American Journal of Pathology 193:6, pages 656-668.
Crossref
Hongdi Ma, Taidou Hu, Wanyin Tao, Jiyu Tong, Zili Han, Dietmar Herndler-Brandstetter, Zheng Wei, Ruize Liu, Tingyue Zhou, Qiuyuan Liu, Xuemei Xu, Kaiguang Zhang, Rongbin Zhou, Judy H. Cho, Hua-Bing Li, Hailiang Huang, Richard A. Flavell & Shu Zhu. (2023) A lncRNA from an inflammatory bowel disease risk locus maintains intestinal host-commensal homeostasis. Cell Research 33:5, pages 372-388.
Crossref
Emmanuelle H Crost, Erika Coletto, Andrew Bell & Nathalie Juge. (2023) Ruminococcus gnavus : friend or foe for human health . FEMS Microbiology Reviews 47:2.
Crossref
Cassandra Mah, Thisun Jayawardana, Gary Leong, Sabrina Koentgen, Daniel Lemberg, Susan J. Connor, Theodore Rokkas, Michael C. Grimm, Steven T. Leach & Georgina L. Hold. (2023) Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic Review. Pathogens 12:2, pages 262.
Crossref
Miikka Höyhtyä, Katri Korpela, Schahzad Saqib, Sofia Junkkari, Eija Nissilä, Anne Nikkonen, Evgenia Dikareva, Anne Salonen, Willem M de Vos & Kaija-Leena Kolho. (2023) Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor α Antagonist Infliximab in Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases 29:1, pages 116-124.
Crossref
Hanan Balto, Solaiman Al-Hadlaq, Abdulmalik Alhadlaq & Afaf El-Ansary. (2023) Gum-gut axis: The potential role of salivary biomarkers in the diagnosis and monitoring progress of inflammatory bowel diseases. The Saudi Dental Journal 35:1, pages 24-30.
Crossref
D Taylor Hendrixson, Nino Naskidashvili, Kevin B Stephenson, Marie L Laury, Aminata Shamit Koroma & Mark J Manary. (2022) An Alternative Oat–Containing, Ready-To-Use, Therapeutic Food Does Not Alter Intestinal Permeability or the 16S Ribosomal RNA Fecal Microbiome Configuration Among Children With Severe Malnutrition in Sierra Leone: A Randomized Controlled Trial. The Journal of Nutrition 152:12, pages 2744-2753.
Crossref
Guanlan Liu, Israr Khan, Yuxi Li, Yun Yang, Xuerui Lu, Yafei Wang, Junxiang Li & Chunjiang Zhang. (2022) Overcoming Anxiety Disorder by Probiotic Lactiplantibacillus plantarum LZU-J-TSL6 through Regulating Intestinal Homeostasis. Foods 11:22, pages 3596.
Crossref
Babak Khorsand, Hamid Asadzadeh Aghdaei, Ehsan Nazemalhosseini-Mojarad, Bahareh Nadalian, Banafsheh Nadalian & Hamidreza Houri. (2022) Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn’s disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Isabella Fraschilla, Hajera Amatullah, Raza-Ur Rahman & Kate L. Jeffrey. (2022) Immune chromatin reader SP140 regulates microbiota and risk for inflammatory bowel disease. Cell Host & Microbe 30:10, pages 1370-1381.e5.
Crossref
Yuhang Li, Juxiong Liu, Bojian Ye, Yueyao Cui, Ruiqi Geng, Shu Liu, Yufei Zhang, Wenjin Guo & Shoupeng Fu. (2022) Astaxanthin Alleviates Nonalcoholic Fatty Liver Disease by Regulating the Intestinal Flora and Targeting the AMPK/Nrf2 Signal Axis. Journal of Agricultural and Food Chemistry 70:34, pages 10620-10634.
Crossref
Christine Olbjørn, Milada Cvancarova Småstuen & Aina Elisabeth Fossum Moen. (2022) Targeted Analysis of the Gut Microbiome for Diagnosis, Prognosis and Treatment Individualization in Pediatric Inflammatory Bowel Disease. Microorganisms 10:7, pages 1273.
Crossref
Rebecka Ventin-Holmberg, Miikka Höyhtyä, Schahzad Saqib, Katri Korpela, Anne Nikkonen, Anne Salonen, Willem M. de Vos & Kaija-Leena Kolho. (2022) The gut fungal and bacterial microbiota in pediatric patients with inflammatory bowel disease introduced to treatment with anti-tumor necrosis factor-α. Scientific Reports 12:1.
Crossref
Wenxuan Zuo, Beibei Wang, Xin Bai, Yihui Luan, Yingying Fan, Sonia Michail & Fengzhu Sun. (2022) 16S rRNA and metagenomic shotgun sequencing data revealed consistent patterns of gut microbiome signature in pediatric ulcerative colitis. Scientific Reports 12:1.
Crossref
Qi-Qi Li, Hui-Hong Zhang & Shi-Xue Dai. (2022) New Insights and Advances in Pathogenesis and Treatment of Very Early Onset Inflammatory Bowel Disease. Frontiers in Pediatrics 10.
Crossref
Mallory Little, Moumita Dutta, Hao Li, Adam Matson, Xiaojian Shi, Gabby Mascarinas, Bruk Molla, Kris Weigel, Haiwei Gu, Sridhar Mani & Julia Yue Cui. (2022) Understanding the physiological functions of the host xenobiotic-sensing nuclear receptors PXR and CAR on the gut microbiome using genetically modified mice. Acta Pharmaceutica Sinica B 12:2, pages 801-820.
Crossref
Mario Guslandi. 2022. Probiotics. Probiotics 343 353 .
Amélia Sarmento & Catarina D. Simões. 2022. Comprehensive Gut Microbiota. Comprehensive Gut Microbiota 423 441 .
Meiyi Hu, Li Zhang, Zheng Ruan, Peiheng Han & Yujuan Yu. (2021) The Regulatory Effects of Citrus Peel Powder on Liver Metabolites and Gut Flora in Mice with Non-Alcoholic Fatty Liver Disease (NAFLD). Foods 10:12, pages 3022.
Crossref
Elizabeth A. Spencer & Marla C. Dubinsky. (2021) Precision Medicine in Pediatric Inflammatory Bowel Disease. Pediatric Clinics of North America 68:6, pages 1171-1190.
Crossref
Lorenza Putignani, Salvatore Oliva, Sara Isoldi, Federica Del Chierico, Claudia Carissimi, Ilaria Laudadio, Salvatore Cucchiara & Laura Stronati. (2021) Fecal and mucosal microbiota profiling in pediatric inflammatory bowel diseases. European Journal of Gastroenterology & Hepatology 33:11, pages 1376-1386.
Crossref
Rachel S. Fitzgerald, Ian R. Sanderson & Marcus J. Claesson. (2021) Paediatric Inflammatory Bowel Disease and its Relationship with the Microbiome. Microbial Ecology 82:4, pages 833-844.
Crossref
Xiao Guo, Xuedan Cao, Xiugui Fang, Ailing Guo & Erhu Li. (2021) Inhibitory effects of fermented Ougan ( Citrus reticulata cv. Suavissima ) juice on high-fat diet-induced obesity associated with white adipose tissue browning and gut microbiota modulation in mice . Food & Function 12:19, pages 9300-9314.
Crossref
Jakub Ruszkowski, Agnieszka Daca, Adrian Szewczyk, Alicja Dębska-Ślizień & Jacek M. Witkowski. (2021) The influence of biologics on the microbiome in immune-mediated inflammatory diseases: A systematic review. Biomedicine & Pharmacotherapy 141, pages 111904.
Crossref
Valerio Baldelli, Franco Scaldaferri, Lorenza Putignani & Federica Del Chierico. (2021) The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases. Microorganisms 9:4, pages 697.
Crossref
Aleksandra Danielak, Dagmara Wojcik, Agnieszka Mazur-Bialy, Marcin Surmiak, Jan Bilski, Aneta Targosz, Marcin Magierowski, Anna Chmura, Malgorzata Strzalka, Gracjana Krzysiek-Maczka, Katarzyna Magierowska, Urszula Szczyrk, Sławomir Kwiecien, Agata Ptak-Belowska & Tomasz Brzozowski. (2021) Intestinal Alkaline Phosphatase Combined with Voluntary Physical Activity Alleviates Experimental Colitis in Obese Mice. Involvement of Oxidative Stress, Myokines, Adipokines and Proinflammatory Biomarkers. Antioxidants 10:2, pages 240.
Crossref
Xiaojun Zhuang, Caiguang Liu, Shukai Zhan, Zhenyi Tian, Na Li, Ren Mao, Zhirong Zeng & Minhu Chen. (2021) Gut Microbiota Profile in Pediatric Patients With Inflammatory Bowel Disease: A Systematic Review. Frontiers in Pediatrics 9.
Crossref
Khalid Elmaghrawy, Séamus Hussey & Gary P. Moran. (2021) The Oral Microbiome in Pediatric IBD: A Source of Pathobionts or Biomarkers?. Frontiers in Pediatrics 8.
Crossref
Lucia Cococcioni, Simona Panelli, Ilaria Varotto-Boccazzi, Domenico Di Carlo, Dario Pistone, Gabriella Leccese, Gian Vincenzo Zuccotti & Francesco Comandatore. (2021) IBDs and the pediatric age: Their peculiarities and the involvement of the microbiota. Digestive and Liver Disease 53:1, pages 17-25.
Crossref
Anna Strömbeck, Anders Lasson, Hans Strid, Johanna Sundin, Per-Ove Stotzer, Magnus Simrén, Maria K. Magnusson & Lena Öhman. (2020) Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn’s disease. BMC Gastroenterology 20:1.
Crossref
Genelle R. Healey, Larissa S. Celiberto, Soo Min Lee & Kevan Jacobson. (2020) Fiber and Prebiotic Interventions in Pediatric Inflammatory Bowel Disease: What Role Does the Gut Microbiome Play?. Nutrients 12:10, pages 3204.
Crossref
Andrew Bell, Emmanuele Severi, Micah Lee, Serena Monaco, Dimitrios Latousakis, Jesus Angulo, Gavin H. Thomas, James H. Naismith & Nathalie Juge. (2020) Uncovering a novel molecular mechanism for scavenging sialic acids in bacteria. Journal of Biological Chemistry 295:40, pages 13724-13736.
Crossref
Roberto de Paula do Nascimento, Ana Paula da Fonseca Machado, Julio Galvez, Cinthia Baú Betim Cazarin & Mario Roberto Maróstica Junior. (2020) Ulcerative colitis: Gut microbiota, immunopathogenesis and application of natural products in animal models. Life Sciences 258, pages 118129.
Crossref
Kangliang Sheng, Guanghui Zhang, Ming Sun, Shiman He, Xiaowei Kong, Jingmin Wang, Fenfang Zhu, Xiangdong Zha & Yongzhong Wang. (2020) Grape seed proanthocyanidin extract ameliorates dextran sulfate sodium-induced colitis through intestinal barrier improvement, oxidative stress reduction, and inflammatory cytokines and gut microbiota modulation. Food & Function 11:9, pages 7817-7829.
Crossref
Sowon Park, Yunkoo Kang, Hong Koh & Seung Kim. (2020) Increasing incidence of inflammatory bowel disease in children and adolescents: significance of environmental factors. Clinical and Experimental Pediatrics 63:9, pages 337-344.
Crossref
Maria Manuela Estevinho, Cátia Rocha, Luís Correia, Paula Lago, Paula Ministro, Francisco Portela, Eunice Trindade, Joana Afonso, Laurent Peyrin-Biroulet & Fernando Magro. (2020) Features of Fecal and Colon Microbiomes Associate With Responses to Biologic Therapies for Inflammatory Bowel Diseases: A Systematic Review. Clinical Gastroenterology and Hepatology 18:5, pages 1054-1069.
Crossref
Lihong Chen, Courtney Reynolds, Robert David & Amy Peace Brewer. (2019) Development of an Index Score for Intestinal Inflammation-Associated Dysbiosis Using Real-World Stool Test Results. Digestive Diseases and Sciences 65:4, pages 1111-1124.
Crossref
Kinga Kowalska-Duplaga, Przemysław Kapusta, Tomasz Gosiewski, Agnieszka Sroka-Oleksiak, Agnieszka H. Ludwig-Słomczyńska, Paweł P. Wołkow & Krzysztof Fyderek. (2020) Changes in the Intestinal Microbiota Are Seen Following Treatment with Infliximab in Children with Crohn’s Disease. Journal of Clinical Medicine 9:3, pages 687.
Crossref
Eva Klingberg, Maria K. Magnusson, Hans Strid, Anna Deminger, Arne Ståhl, Johanna Sundin, Magnus Simrén, Hans Carlsten, Lena Öhman & Helena Forsblad-d’Elia. (2019) A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin. Arthritis Research & Therapy 21:1.
Crossref
Andrew Bell, Jason Brunt, Emmanuelle Crost, Laura Vaux, Ridvan Nepravishta, C. David Owen, Dimitrios Latousakis, An Xiao, Wanqing Li, Xi Chen, Martin A. Walsh, Jan Claesen, Jesus Angulo, Gavin H. Thomas & Nathalie Juge. (2019) Elucidation of a sialic acid metabolism pathway in mucus-foraging Ruminococcus gnavus unravels mechanisms of bacterial adaptation to the gut. Nature Microbiology 4:12, pages 2393-2404.
Crossref
Mary Ellen Sanders, Daniel J. Merenstein, Gregor Reid, Glenn R. Gibson & Robert A. Rastall. (2019) Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nature Reviews Gastroenterology & Hepatology 16:10, pages 605-616.
Crossref
M. K. Vester-Andersen, H. C. Mirsepasi-Lauridsen, M. V. Prosberg, C. O. Mortensen, C. Träger, K. Skovsen, T. Thorkilgaard, C. Nøjgaard, I. Vind, K. A. Krogfelt, N. Sørensen, F. Bendtsen & A. M. Petersen. (2019) Increased abundance of proteobacteria in aggressive Crohn’s disease seven years after diagnosis. Scientific Reports 9:1.
Crossref